gemcitabine has been researched along with glaucarubinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, GS; Beutler, JA; Christophi, C; He, H; Huynh, N; Nikfarjam, M; Shulkes, A; Yeo, D | 1 |
| Baldwin, GS; Beutler, JA; He, H; Huynh, N; Nikfarjam, M; Yeo, D | 1 |
2 other study(ies) available for gemcitabine and glaucarubinone
| Article | Year |
|---|---|
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Down-Regulation; Drug Synergism; Enzyme Activation; Gemcitabine; Glaucarubin; Humans; Mice; Mice, Nude; p21-Activated Kinases; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Glaucarubinone Combined with Gemcitabine Improves Pancreatic Cancer Survival in an Immunocompetent Orthotopic Murine Model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Glaucarubin; Mice; Neoplasms, Experimental; Pancreatic Neoplasms | 2016 |